Intrinsic value of Genmab A/S (GMAB)
Live fair value data for Genmab A/S (GMAB) is currently unavailable. Please check again shortly.
Current Price: $139.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Genmab A/S (GMAB) undervalued or overvalued?
Based on the current model output, Genmab A/S appears to be undervalued with a upside of 42.00%.
Fair value vs market price — Genmab A/S (GMAB)
Unlock premium access to view the live fair value comparison against current market price for GMAB.
Frequently Asked Questions - GMAB
How is GMAB intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for GMAB.
Is GMAB undervalued or overvalued right now?
GMAB is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for GMAB: open their intrinsic value pages.